Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Bioavailable capsule compositions of amorphous alpha-(N-sulfonamido)acetamide compound

Bioavailable capsule compositions of amorphous alpha-(N-sulfonamido)acetamide compound

US Patent 8252821 · Granted Aug 28, 2012

Estimated economic value: $87,514,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Enhanced performance of amorphous solid and solubilized formulations for achievi2025
Formulations comprising triptan compounds2024
Use of C-type natriuretic peptide variants to treat skeletal dysplasia2024
Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane c2024
Use of C-type natriuretic peptide variants to treat skeletal dysplasia2024
Use of C-type natriuretic peptide variants to treat skeletal dysplasia2023
Formulations comprising triptan compounds2022
Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane c2021
Variants of C-type natriuretic peptide2020
Use of C-type natriuretic peptide variants to treat skeletal dysplasia2020
Formulations comprising triptan compounds2020
Prostate specific membrane antigen (PSMA) targeted nanoparticles for therapy of 2019